OPKO HEALTH, INC. OPK on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0000944809
0000944809
EIN:
75-2402409
75-2402409
LEI:
(CF Office: 03 Life Sciences)
Business address:
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Phone: 305-575-4181
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Phone: 305-575-4181
Mailing address:
4400 BISCAYNE BLVD., MIAMI, FL, 33137
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Category:
Large accelerated filer
Large accelerated filer
Former names:
- EXEGENICS INC - filings through 2007-06-13
- eXegenics Inc - filings through 2007-06-13
- CYTOCLONAL PHARMACEUTICS INC /DE - filings through 2001-06-04
Filings:
2,943 EDGAR filings since May 13, 1996
2,943 EDGAR filings since May 13, 1996
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 28, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- March 21, 2025 - 10-K/A: Annual report for year ending December 31, 2024 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 14, 2025 - ARS: Annual Report to Security Holders Open documentClick to Open document FilingOpen filingClick to Open filing
- March 14, 2025 - DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material Open documentClick to Open document FilingOpen filingClick to Open filing
- March 14, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- March 28, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- March 11, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 15, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 21, 2025 - 10-K/A: Annual report for year ending December 31, 2024 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 3, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 7, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 7, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 7, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- March 14, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- August 30, 2024 - DEFR14A: Revised definitive proxy soliciting materials Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 28, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- November 20, 2024 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 15, 2024 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 13, 2024 - SC 13G: Statement of acquisition of beneficial ownership by individuals Open documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 1,002 entries
Data source:
CIK0000944809.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
